ABOUT CMB

  1. HOME
  2. About CMB
  3. Greetings

Greetings

Research Director MIYAZAKI Koyomi

Cellular and Molecular Biotechnology Research Institute (CMBRI) has been newly established on April 1, 2020, coinciding with the start of the fifth Medium-to long-term Plan of AIST. To contribute to the analyses of important molecules governing biological phenomena, we will provide the state-of-the-art technologies in areas ranging from drug discovery, medicine to health care. The research scientists at Cellular and Molecular Biology Research Institute have been selected from the former three institutes (Biotechnology Research Institute for Drug Discovery, Molecular Profiling Research Center for Drug Discovery, and Biomedical Research Institute) based on their expertise in sugar chain analysis, stem cell technologies, identifying bioactives from natural resources, bio-measurement, and bio-IT. By combining these expertise, we aim to promote the development of technologies for regenerative medicine, individually-tailored medicine, and health & longevity.

Many of our technologies at AIST are now approaching commercialization phase. With our experience in collaborative research with industries to date, we aim to provide advanced technologies that match the needs of society and lead industry more than ever during the 5th midterm program of AIST. Since a wide range of technologies, including IT, sensors, environments, and material chemistry, are interfaced with humans, understanding of basic biology is vital to the consummation of novel technologies. We will contribute to health and longevity of people through interdisciplinary R&D by collaborating with other Research Institutes of Department of Life Science and Biotechnology as well as other Departments of AIST, whenever necessary. Additionally, we host one of the two international collaboration hubs of AIST that promote collaborative research with research institutes overseas, namely AIST-INDIA DAILAB. We are also collaborating with research institutes in Thailand as well as China. While promoting global collaboration in R&D, we aim to cultivate human resources and produce business seeds.

I appreciate your understanding to the vision of Cellular and Molecular Biotechnology Research Institute and welcome feedback to further promote research to contribute to society.

Research Director
MIYAZAKI Koyomi

Page Top